Lifechamps aims to address the inherent complexity caused by cancer treatments and to act in the monitoring of health status and improvement of quality of life in a significant manner by using emerging technologies in the fields of Big Data, Data Analytics and Artificial Intelligence. In essence, LifeChamps delivers a novel, context-aware and large-scale analytics framework capable of delivering multi-dimensional Quality of Life (QOL) support to all the different cancer life champions during and after their treatments. LifeChamps is providing support to middle aged and older (pre-frail and frail) cancer patients, as well as their caregivers and healthcare professionals, with an integrated Big Data-driven solution capable to improve their QOL via a timely and more accurate clinical decision support at the point of care. Its Artificial Intelligence (AI) and analytics engine, running both at the cloud and at the mobile edge, can determine accurately which factors affect the oncological patients’ QOL the most, during and after their treatment. Furthermore, complemented by a health recommender system LifeChamps offers personalized healthcare services (such as symptom monitoring, treatment and rehabilitation) to these patients and their caregivers. The LifeChamps platform will be validated in four multi-national pilot use case scenarios aimed at demonstrating its applicability and validity for all the requirements of the SC1-DTH01-2019 Call, namely Prediction, Care, and Advice.
Official website: https://lifechamps.eu
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 875329